Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Atyr Pharma Inc (LIFE)

2.4 -0.05 (-2.04%)

04-20 16:00

Open:

2.45

Pre. Close:

2.45

High:

2.45

Low:

2.35

Volume:

43,321

Market Cap:

72M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.455 - 2.469

2.469 - 2.484

Low:

2.312 - 2.327

2.327 - 2.343

Close:

2.371 - 2.398

2.398 - 2.427

Technical analysis  (as of: 2018-04-20 4:31:28 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 3.29     One year: 3.62

Support:

Support1: 2.35    Support2: 1.96

Resistance:

Resistance1: 2.81    Resistance2: 3.10

Pivot:

2.64

Moving Averages:

MA(5): 2.52     MA(20): 2.69

MA(100): 3.36     MA(250): 3.57

MACD:

MACD(12,26): -0.13     Signal(12,26,9): -0.11

%K %D:

%K(14,3): 8.33     %D(3): 8.81

RSI:

RSI(14): 28.70

52-Week:

High: 6.496  Low: 2.3  Change(%): -23.8

Average Vol(K):

3-Month: 4852  10-Days 2504

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
LIFE has closed below the lower band by 7.9%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 27.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-03-19T22:25:06-04:00
aTyr Pharma's (LIFE) CEO Dr. Sanjay Shukla on Q4 2017 Results - Earnings Call Transcript

2018-03-19T16:09:44-04:00
aTyr Pharma beats by $0.02

2018-02-22T11:53:40-05:00
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2017 Update

2018-02-14T08:57:10-05:00
Premarket analyst action - healthcare

2018-01-11T14:14:09-05:00
aTyr Pharma (LIFE) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow

2017-11-21T03:22:06-05:00
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q3 2017 Update

2017-09-30T18:11:03-04:00
Faison's Weekend Review And Scans

2017-09-26T13:32:14-04:00
aTyr Pharma (LIFE) Presents At Ladenburg Thalmann 2017 Healthcare Conference - Slideshow

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

29.80

Shares Float (M)

29.15

% Held by Insiders

% Held by Institutions

62.80

Shares Short (K)

195

Shares Short Prior Month (K)

301

Stock Financials

EPS

-1.890

EPS Est. Current Year

-2.180

EPS Est. Next Year

-1.820

EPS Est. Next Quarter

-0.460

Forward EPS

-1.382

Book Value (p.s.)

1.250

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-53.2

Return on Equity (ttm)

-70.9

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.188

Qtrly Earnings Growth

Operating Cash Flow (M)

-42.36

Levered Free Cash Flow (M)

-25.14

atoplab.com

Valuation

P/E

-1.27

P/E Growth Ratio

-0.02

P/BV

1.92

P/S

P/CF

-1.69

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.